Emerging therapies for MASLD and their impact on plasma lipids

• Autori principali: Madison Nguyen (Autore), Amon Asgharpour (Autore), Dave L. Dixon (Autore), Arun J. Sanyal (Autore), Anurag Mehta (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Metabolic-dysfunction associated steatotic liver disease (MASLD) affects 1 out of every 3 individuals in the adult population and the disease prevalence is predicted to increase worldwide. Patients with MASLD are also burdened by cardiovascular disease, which is the leading cause of mortality in thi...